FindTrial
Sign In

Atorva-af prevention study

Atorva-af prevention study - Atorva-af prevention study

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000002371
Enrollment
180
Registered
2009-10-01
Start date
2009-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic heart disease

Interventions

preoperative statin treated no statin treated

Sponsors

Showa University School of Medicine Thoracic and cardiovascular surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: statin group: LDL cho > 100 mg/dL adminisnistered statin control group: LDL cho < 100 mg/dL without statin treatment

Exclusion criteria

Exclusion criteria: preoperative Af aberrant high level of liver enzyme disorder muscle steroid administration severe renal dysfunction severe liver dysfunction past history of severe allergy

Design outcomes

Primary

MeasureTime frame
occurrence of Af—

Countries

Japan

Contacts

Public ContactTadamasa Miyauchi

Showa University Thoracic and cardiovascular surgery

miyauchi@med.showa-u.ac.jp03-3784-8588

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026